Expression, purification, and characterization of recombinant human factor X

Protein Expression and Purification

Volumn 10, Issue 3, 1997, Pages 373-378

  Rudolph, Amy E ^a   Mullane, Michael P ^a   Porche Sorbet, Rhonda ^a   Miletich, Joseph P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRICETINAE; VIPER;

EID: 0031214814     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1997.0752     Document Type: Article

References (28)

1. Krishnaswamy S. Prothrombinase complex assembly: Contributions of protein-protein and protein-membrane interactions toward complex formation. J. Biol. Chem. 265:1990;3708-3718.
2. Di Scipio R. G., Hermodson M. A., Davie E. W. Activation of human factor X (Stuart factor) by a protease from Russell's viper venom. Biochemistry. 16:1977;5253-5260.
3. Jesty J., Spencer A. K., Nemerson Y. The mechanism of activation of factor X: Kinetic control of alternative pathways leading to the formation of activated factor X. J. Biol. Chem. 249:1974;5614-5622.
4. Pfeiffer R. A., Ott R., Gilgenkrantz S., Alexandre P. Deficiency of coagulation factors VII and X associated with deletion of a chromosome 13 (q34): Evidence from two cases with 46, XY, t(13;Y)(q11;q34). Hum. Genet. 62:1982;358-360.
5. Nemerson Y., Bach R. Tissue factor revisited. Prog. Hemostasis Thromb. 6:1982;237-261.
6. Nemerson Y. Tissue factor and hemostasis. Blood. 71:1986;1-8.
7. Mann K. G., Jenny R. J., Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu. Rev. Biochem. 57:1988;915-956.
8. Rosenberg R. D., Damus P. S. The purification and mechanism of action of human antithrombin-heparin cofactor. J. Biol. Chem. 248:1973;6490-6505.
9. Owen B. A., Owen W. G. Interaction of factor Xa with heparin does not contribute to the inhibition of factor Xa by antithrombin III-heparin. Biochemistry. 29:1990;9412-9417.
10. Broze G. J. Jr., Warren L. A., Novotny W. F., Higuchi D. A., Girard J. J., Miletich J. P. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood. 71:1988;335-343.
11. Griard T. J., Warren L. A., Novotny W. F., Higuchi D. A., Girard J. J., Miletich J. P. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 338:1989;518-520.
12. Rezaie A. R., Neuenschwander P. F., Morrissey J. H., Esmon C. T. Analysis of the functions of the first epidermal growth factor-like domain of factor X. J. Biol. Chem. 268:1993;8176-8180.
13. Racchi M., Watzke H. H., High K. A., Lively M. O. Human coagulation factor X deficiency caused by a mutant signal peptide that blocks cleavage by signal peptidase but not targeting and translocation to the endoplasmic reticulum. J. Biol. Chem. 268:1993;5735-5740.
14. Kim D. J., Girolami A., James H. L. Characterization of recombinant human coagulation factor X (Fruili). Thromb. Hemostasis. 75:1996;313-317.
15. Rudolph A. E., Mullane M. P., Tsuda S., Porche-Sorbet R., Miletich J. P. Factor X (St. Louis II) - Identification of a glycine substitution at residue 7 and characterization of the recombinant protein. J. Biol. Chem. 271:1996;28601-28606.
16. Fass D. N., Knutson G. J., Katzmann J. A. Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein. Blood. 59:1992;594-600.
17. Kisiel W., Hermodson M. A., Davie E. W. X activating enzyme from Russell's viper venom: Isolation and characterization. Biochemistry. 15:1976;4901-4906.
18. Graham F., Eb A. J. Transformation of rat cells by DNA of human adenovirus 5. Virology. 52:1973;456-467.
19. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
20. MacDonald R. C., MacDonald R. I., Menco B. Ph. M., Takeshita K., Subbarao N. K., Hu L. Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim. Biophys. Acta. 1061:1991;297-303.
21. Rehemtulla A., Dorner A. J., Kaufman R. J. Regulation of PACE propeptide-processing activity: Requirement for a post-endoplasmic reticulum compartment and autoproteolytic activation. Proc. Natl. Acad. Sci. USA. 89:1992;8235-8239.
22. Wise R. J., Barr P. J., Wong P. A., Kiefer M. C., Brake A. J., Kaufman R. J. Expression of a human proprotein processing enzyme: Correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. Proc. Natl. Acad. Sci. USA. 87:1990;9378-9382.
23. Nakagaki T., Foster D. C., Berkner K. L., Kisiel W. Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry. 30:1991;10819-10824.
24. Kazama Y., Foster D. C., Kisiel W. Evidence that an Arg79 → Gln substitution in human factor VII is not associated with a reduction in coagulant activity. Blood Coagulation Fibrinolysis. 3:1992;697-702.
25. Boskovic D. S., Giles A. R., Nesheim M. E. Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-LL. J. Biol. Chem. 265:1990;10497-10505.
26. Miletich J. P., Jackson C. M., Majerus P. W. Interaction of coagulation factor Xa with human platelets. Proc. Natl. Acad. Sci. USA. 74:1977;4033-4036.
27. Miletich J. P., Jackson C. M., Majerus P. W. Properties of the factor Xa binding site on human platelets. J. Biol. Chem. 253:1978;6908-6916.
28. Craig P. A., Olson S. T., Shore J. D. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III: Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction. J. Biol. Chem. 264:1989;5452-5461.